Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) has been assigned a consensus rating of “Hold” from the fifteen brokerages that are currently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a sell rating, five have given a hold rating, seven have given a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $29.8462.
ACHC has been the topic of a number of research reports. KeyCorp raised their price target on Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. UBS Group increased their price objective on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 9th. Jefferies Financial Group raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their target price for the company from $24.50 to $30.00 in a report on Wednesday, June 3rd. TD Cowen upped their price target on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, September 9th.
Get Our Latest Stock Report on Acadia Healthcare
Hedge Funds Weigh In On Acadia Healthcare
Acadia Healthcare Stock Down 1.7%
ACHC stock opened at $28.33 on Friday. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20. Acadia Healthcare has a twelve month low of $11.43 and a twelve month high of $35.83. The company’s 50 day moving average is $30.15 and its two-hundred day moving average is $27.19. The stock has a market cap of $2.64 billion, a P/E ratio of -2.28, a PEG ratio of 9.13 and a beta of 0.62.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.03. The firm had revenue of $865.84 million during the quarter, compared to analysts’ expectations of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. Acadia Healthcare’s quarterly revenue was down .4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Research analysts expect that Acadia Healthcare will post 1.55 earnings per share for the current fiscal year.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The company operates facilities that offer treatment for mental health conditions, substance use disorders and other behavioral health needs. Its services are designed for children, adolescents and adults and may include inpatient psychiatric care, residential treatment, outpatient programs and specialized care.
Acadia’s facilities provide a range of treatment programs, including psychiatric hospitals, addiction treatment centers, eating disorder programs and other specialty behavioral healthcare services.
Featured Stories
- Five stocks we like better than Acadia Healthcare
- Lennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. Housing
- Priced for a Pullback or More Gains? These 3 Stocks Are Testing the Limits
- These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth Stories
- Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
